Identification of novel autoantibodies in Sjögren’s disease
Frontiers in Immunology · 2025
DOI: 10.3389/fimmu.2025.1524940 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Immunology, 2025. Verfasst von Fiona Engelke und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Clinical Immunology, Hannover Medical School, Hanover, Germany. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Autoantibodies. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The diagnosis of Sjögren’s disease (SjD) in patients without autoantibodies against Ro/SSA is a major challenge. We aimed to identify novel autoantibodies in SjD that may facilitate the diagnostic procedure for Ro/SSA negative SjD.
Methods
IgG and IgA autoantibody reactivity of 94 potential candidate autoantigens for SjD, selected from a discovery screen of 1,629 human antigens coupled to Luminex beads and prior knowledge about potential biological relevance, were examined in serum of SjD patients (n=347) using Luminex and ELISA technology. Healthy (HC, n=118) and non-Sjögren’s sicca syndrome (NSS, n=44) individuals served as controls. To assess disease specificity, the novel autoantibodies were also measured in serum of patients with Rheumatoid Arthritis (RA, n=50), Systemic Lupus Erythematosus (SLE, n=49), and Systemic Sclerosis (SSc, n=37).
Results
45 novel autoantibodies were significantly (p ≤ 0.05) more prevalent in SjD than in HC and were detected in up to 19% of the SjD cohort. The most common autoantibodies were against CCL4, M5, TMPO and OAS3. Some of the novel autoantibodies were associated with extraglandular disease manifestations, such as anti-TONSL or anti-IL6 with pulmonary involvement. We have developed a three and five marker panel for the detection of Ro/SSA negative patients, consisting of anti-FNBP4, anti-SNRPC, anti-CCL4, anti-M3 and anti-KDM6B, which had a sensitivity of up to 46% with a specificity of 95% (SjD vs. HC). Both panels discriminate these patients from HC, whereas the three-marker more effectively differentiates between Ro/SSA negative patients and NSS.
Discussion
Novel autoantibodies will facilitate the diagnosis of Ro/SSA negative patients with SjD, in particular our predictive panel will be useful in the diagnosis and differentiation of these patients from healthy and NSS individuals in a clinical context. In addition, the autoantibodies may also be useful for risk stratification of extraglandular manifestations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Clinical Immunology, Hannover Medical School, Hanover, Germany.
- Oncimmune Germany GmbH, Dortmund, Germany.
- Department of Medicine, University of Udine, Udine, Italy.
- Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- Department of Respiratory Medicine, Hannover Medical School, Hanover, Germany.
- CellTrend GmbH, Luckenwalde, Germany.
Zitieren
APA
Engelke, F., Budde, P., De Vita, S., Dörner, T., Ernst, D., Gras, J., Heidecke, H., Kilian, A. L., Kniesch, K., Lindemann, A. S., Quartuccio, L., Ritter, J., Schulze-Forster, K., Seeliger, B., Zucht, H. D., & Witte, T. (2025). Identification of novel autoantibodies in Sjögren’s disease. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2025.1524940
Vancouver
Engelke F, Budde P, De Vita S, Dörner T, Ernst D, Gras J, et al. Identification of novel autoantibodies in Sjögren’s disease. Frontiers in Immunology. 2025. doi:10.3389/fimmu.2025.1524940
BibTeX
@article{Engelke2025,
author = {Engelke, Fiona and Budde, Petra and De Vita, Salvatore and Dörner, Thomas and Ernst, Diana and Gras, Jan and Heidecke, Harald and Kilian, Annika Loredana and Kniesch, Katja and Lindemann, Ann-Sophie and Quartuccio, Luca and Ritter, Jacob and Schulze-Forster, Kai and Seeliger, Benjamin and Zucht, Hans-Dieter and Witte, Torsten},
title = {Identification of novel autoantibodies in Sjögren’s disease},
journal = {Frontiers in Immunology},
year = {2025},
doi = {10.3389/fimmu.2025.1524940}
}
EUVIMED